Malignant Brain Neoplasm: Clinical Trials

5 trials for Malignant Brain Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 active not recruiting, 1 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 3, Active not recruiting 1, Unknown 1
Phase 11Recruiting 1

Follow Malignant Brain Neoplasm: new trials by email Literature Review of Malignant Brain Neoplasm trials Research Report on Malignant Brain Neoplasm

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
Computed Tomography, Fluorodopa F 18, Positron Emission Tomography - Malignant Brain Neoplasm
Phase 2RecruitingMayo Clinic472026-03-242026-04-28
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
Biospecimen Collection, Computed Tomography, Dexamethasone - Low Grade Glioma, Malignant Brain Glioma
Phase 2RecruitingEmory University2002025-01-092026-02-10
Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy
Best Practice, Medical Device Usage and Evaluation, Metformin - Malignant Brain Neoplasm
Phase 2Active not recruitingMayo Clinic1002024-05-312026-10-02
Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors
Dexamethasone - Malignant Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain
Phase 2UnknownCity of Hope Medical Center262022-04-092024-09-19
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Malignant Brain Neoplasm, Malignant Glioma
Phase 1 / Phase 2RecruitingStanford University462018-05-162026-06-29

Narrower conditions

Brain Neoplasms (5)  ·  Glioma (1)  ·  Meningioma (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Central Nervous System Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Meningeal Neoplasms (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neoplasms, Vascular Tissue (1)  ·  Neuroectodermal Tumors (1)

Interventions

Calcium Dobesilate (2)  ·  Dexamethasone (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  auricularum (2)  ·  dexamethasone 21-phosphate (2)  ·  dexamethasone acetate (2)  ·  Mental Status and Dementia Tests (1)  ·  Metformin (1)  ·  Panitumumab (1)  ·  Practice Guidelines as Topic (1)  ·  Specimen Handling (1)  ·  Standard of Care (1)  ·  fluorodopa F 18 (1)

Sponsors

Mayo Clinic (2)  ·  City of Hope Medical Center (1)  ·  Emory University (1)  ·  Stanford University (1)

Countries

United States (5)

Top investigators

Derek R. Johnson, MD (1)  ·  Jana L Portnow, MD (1)  ·  Kimberly Hoang, MD (1)  ·  Lindsay Moore, MD (1)  ·  Ugur T. Sener, MD (1)

Results publications

PMID 42211793

NIH funding

P30CA033572 (1), P30CA138292 (1), R01CA190306 (1)